As shown in the survival plot the overexpressed PRMT5 and FXR1 (SD > 1) alone (Supplementary Figure S5A and S5B) or in combination (Figure 8A), lead to poor patient survival in HNSCC and lung cancer patients. Here, PRMT5 is linked to lung carcinoma.